China Money Network
Login
Join

Shenzhen Hepalink Pharma Invests $60M In TPG Biotech Fund

  • June 20, 2016 — 08:19 CST

This Data Is Locked!

This area is available only to Subscribers.

Chinese drug maker Shenzhen Hepalink Pharmaceutical plans to invest US$60 million in TPG Biotechnology Partners V, L.P., which mainly targets biomedical technology and life science... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: